Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems
Sai Balaji Andugulapati, Karthik Gourishetti, Satya Krishna Tirunavalli, Taslim Babru Shaikh, Ramakrishna Sistla
Topics & Concepts
Idiopathic pulmonary fibrosisNintedanibPirfenidoneEx vivoBleomycinIn vivoMedicineCancer researchPulmonary fibrosisMyofibroblastFibrosisPharmacologyPathologyLungBiologyInternal medicineChemotherapyBiotechnologyInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisLung Cancer Treatments and MutationsInhalation and Respiratory Drug Delivery